 (BrJ Ophthalmology 1995; 79: 28-34) 
Abstract
Clinical phenotypes of patients with mutations in the human RDS/peripherin gene are described. A 67-year-old woman, who carried a 1 base pair deletion in codon 307, presented with typical late onset autosomal dominant retinitis pigmentosa (RP). In another autosomal dominant pedigree, a nonsense mutation at codon 46 caused 'inverse' retinitis pigmentosa-like fundus changes associated with progressive cone-rod degeneration in a 58-year-old man, whereas his 40-year-old son presented with yellow deposits in the retinal pigment epithelial layer resembling a pattern dystrophy, and with moderately reduced rod and cone function, as determined by two colour dark adapted threshold perimetry and electroretinography. It is suggested that both clinical pictures within this latter family may represent manifestations of fundus flavimaculatus. The clinical data of the three patients provide further evidence for the remarkable variety of disease expression within and between families with mutations in the RDS/ peripherin gene. Currently, the most comprehensive statement could be that RDS/peripherin mutations are associated either with typical RP or with various forms of flecked retinal disease. (BrJ Ophthalmology 1995; 79: 28-34) The gene for retinal degeneration slow (rds), a mouse model ofhuman retinitis pigmentosa, was cloned in 1989.' The normal gene product is called RDS/peripherin, a protein which localises to the disc rim of photoreceptor outer segments, and which is considered to play a role in maintaining the structure of outer segment discs.23 In the human RDS/peripherin gene,4 mutations were first identified in families with autosomal dominant retinitis pigmentosa (adRP, for review see Farrar et al5). Subsequently, mutations were also found to be associated with fairly different phenotypes, such as macular dystrophy,6 pattern dystrophies of the retinal pigment epithelium (RPE), '8 (Fig 2A) , both eyes showed optic atrophy, severe vessel attenuation, diffuse peripheral RPE, and choriocapillaris atrophy and sparse bone spicule pigmentation. Within the central vascular arcades of both eyes there was some preserved pigment epithelium with atrophic foveal changes. Colour vision testing (right eye) revealed a marked tritan defect. Visual fields ( Fig 3A) were constricted to 6-10°(right eye) and 6-7°(left eye), respectively. The standard ERG was non-recordable (not shown). However,, small remnant amplitudes could be obtained by using scotopic 10 Hz white flicker stimuli at standard intensity and photopic 30 Hz white fficker stimuli at an intensity of 3-6 cds/m2 (see Fig 3B) . On two colour dark adapted threshold perimetry performed along the horizontal meridian of the right eye there was a sensitivity loss of about 3 5 log units to the 500 nm and of 1 5-2 5 log units to the 656 nm stimulus, respectively. Rods mediated thresholds to 500 nm at the peripheral field borders, whereas in the remaining test sites only cone function could be detected.
MOLECULAR GENETIC FINDINGS
Mutation screening in patient II-2 followed by direct sequencing revealed a 1 base pair (bp) deletion in codon 307 (exon III) of the RDS/ peripherin gene, leading to a shift in the reading frame and thus predicting a peripherin molecule truncated by 24 amino acids and substantially altered at its carboxyl terminal end (for details see Gruning et al'2). The 1 bp deletion was neither found in individuals III/1-3, nor in 160 unrelated patients with adRP. visual acuity was 25/20 with a correction of -0 5 cyl A 00 in both eyes. Biomicroscopy revealed clear lenses. On funduscopy (Fig 2C) , the optic discs and the retinal vessels appeared normal. However, multiple yellow-white, medium-sharp defined deposits varying in shape and size could be seen within the RPE layer. Large pisciform plaques were surrounding and partially invading the foveae. Smaller round deposits were scattered in the paramacular areas, and in several posterior midperipheral regions small linear flecks were arranged in a reticular pattern. No bone spicule pigmentations were seen. The equatorial and anterior fundus regions appeared normal. On fluorescein angiography of the right eye (Fig 2D) multiple hyperfluorescent spots appeared in the posterior pole, sparing only the fovea. They did not change during the transit nor stain in the late phases, thus being characteristic of RPE defects. In the fovea, there was a blockade of choroidal fluorescence corresponding to the large deposits seen on funduscopy, which showed a remote resemblance to a butterfly lesion. The desaturated Farnsworth D15 test revealed mild tritanomaly in both eyes. Static perimetry (Fig 4B) , performed with the Tubinger automated perimeter, revealed normal outer field borders, but scattered paracentral scotoma in the inferior fields of both eyes extending from the inferior foveal edge to about 250 peripherally. Marked sensitivity losses (>25 dB) predominated in the right eye which corresponded to the areas of major RPE defects detected by fluorescein angiography, whereas mild threshold elevations (>5-10 dB) were found in the left eye. Two colour dark adapted static perimetry along the vertical meridian of the right eye (Fig SB) revealed a more widespread area of subnormal rod and cone sensitivity, covering the central 300 superiorly and the central 400 inferiorly. Rod sensitivity (to 500 nm) was reduced by about 0 5 log units at 30-400 eccentricity and by 1-15 log units within the central 200. Cone sensitivity to 656 nm, however, was still within normal limits or near normal between 60 inferiorly and 100 superiorly. Cone threshold elevations in the remaining loci varied between 0 5 and I 5 log units. Sensitivity differences confirmed a roughly equal functional loss of rods and cones with a slight preponderance of rod impairment in the perifoveal regions. In the ERG (Fig 6) , isolated rod signals, scotopic mixed rod/cone amplitudes, oscillatory potentials, and light adapted 30 Hz flicker and single flash cone amplitudes were all reduced to about one third of normal mean values. Peak times of rod and cone signals were within the normal range.
Persons III-3 and IV-2 both have no subjective visual complaints and do not show any signs of retinal disease. The offspring of IV-3, individuals V-1 to 3 have not complained of visual problems and currently are not available for ocular examination.
Molecular geneticfindings
DNA samples of III-4 and IV-3 showed a particular SSCP pattern for exon I of the RDS/ peripherin gene. Direct sequencing revealed a C-to-T transition (CGA for TGA) at codon 46 creating an in frame translation stop signal (for details see Meins et al 13).
Discussion
We studied the clinical expression of RDS/ peripherin mutations in three individuals from two different pedigrees. Our data provide further evidence for the highly varying phenotypic expression of RDS/peripherin gene defects between and within families. In one of our patients, who carries a 1 bp deletion in codon 307, the phenotype is a late onset adRP with typical features like disc pallor, vessel attenuation, bone spicule pigment deposits, and peripheral visual field loss. However, the widespread choriocapillaris atrophy observed is not a constant finding in RP. It may be concluded from the history of subjective symptoms in both the missense mutation in codon 167 of the RDS/ peripherin gene had butterfly-shaped pattern dystrophy. The fundus appearance of one of their patients does not differ substantially from that found in IV-3. As a rule however, individuals with pattern dystrophies have normal ERGs and so did the patients with the codon 167 mutation. In contrast, our proband had clearly abnormal ERG results, a finding which has been only sporadically described in pattern dystrophies. '6 7 In addition, IV-3 has moderate but widespread rod and cone sensitivity loss in dark adapted threshold perimetry, a finding which would be unexpected in macular pattern dystrophies. Gass'8 pointed out that the funduscopic findings in fundus flavimaculatus, a diffuse condition, may in some cases be hardly distinguishable from those in pattern dystrophies. The older patient (III-4) with the Arg-46-stop mutation presents with RP-like fundus changes and, with respect to the sequence and pattern of his visual function loss, could be considered as having cone-rod dystrophy (CRD 
